Aiglon Capital Invests in CARPE

Durham, NC – Aiglon Capital announced today an investment in CARPE, a Durham-based manufacturer of antiperspirant hand and foot lotion for the treatment of Hyperhidrosis.

Hyperhidrosis affects about 12% of the US population, and nearly 1 in 5 teenagers. CARPE’S products are dermatologist-recommended, 100% non-irritating, and clinically proven to reduce excessive sweating. It is the leading over-the-counter (OTC) solution for sweaty hands and feet.
CARPE is currently available in pharmacy and retail stores including Harris Teeter, AAP, Amazon, Tennis Warehouse, and soon will be launching in CVS.

About Aiglon Capital Management

Aiglon Capital Management is a private investment firm that acquires, manages, and grows lower middle-market manufacturing, distribution, and services companies. Aiglon Capital seeks to invest in companies that have attractive positions in their markets, where capital is necessary to enhance future growth of the business, or current owners seek liquidity. Aiglon Capital achieves growth by partnering with management teams and leveraging its significant consulting and operational expertise.

For additional information about the firm or its current portfolio of companies, please visit www.aigloncapital.com or contact us at info@aigloncapital.com.

Back to News